Development of novel anti-tuberculosis chemotherapeutic agents
To develop novel anti-tuberculosis agents which are active against multidrug-resistant strains of Mycobacterium tuberculosis, and which interact optimally with the human immune system to eradicate this dangerous microbial pathogen
Researchers involved
|